You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CCCC Exercise Disclosure
Anderson Kenneth Carl · SEC Form 4 · Filed Jun 4, 2026
Exercise
Calculated transaction value
$2.26K
Anderson Kenneth Carl Director
CCCC
C4 Therapeutics
CCCC
Transaction date
Jun 1, 2026
Public filing date
Jun 4, 2026
Filing lag
Filed 3 days later
CCCC daily price context
Close on/before transaction
$4.38
Jun 1, 2026
First close after public filing
$3.85
Jun 5, 2026
30-day return after filing
+7.53%
Through Jul 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,070 shares @ $2.11
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001470831-26-000504
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$2.26K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| C4 Therapeutics, Inc. CCCC Current | Exercise | Jun 1, 2026 | $2.26K |
| C4 Therapeutics, Inc. CCCC | Exercise | Jun 1, 2026 | $0 |